FDA Inspection 819284 — Zhejiang Hisoar Pharmaceutical Co. Ltd.
The FDA completed an inspection of Zhejiang Hisoar Pharmaceutical Co. Ltd. on January 18, 2013 in Taizhou. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- January 18, 2013
- Fiscal Year
- 2013
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Taizhou (China)